Grant number: 103462 | Funding period: 2018 - 2028
Active
CA Jahangir, DB Page, G Broeckx, CA Gonzalez, C Burke, C Murphy, JS Reis-Filho, A Ly, PW Harms, RR Gupta, M Vieth, AI Hida, M Kahila, Z Kos, PJ van Diest, S Verbandt, J Thagaard, R Khiroya, K Abduljabbar, G Acosta Haab
2024-03-01
Recent advances in the field of immuno-oncology have brought transformative changes in the management of cancer patients. The immu..
J Thagaard, G Broeckx, DB Page, CA Jahangir, S Verbandt, Z Kos, R Gupta, R Khiroya, K Abduljabbar, G Acosta Haab, B Acs, G Akturk, JS Almeida, I Alvarado-Cabrero, M Amgad, F Azmoudeh-Ardalan, S Badve, NB Baharun, E Balslev, ER Bellolio
2023-08-01
The clinical significance of the tumor-immune interaction in breast cancer is now established, and tumor-infiltrating lymphocytes ..
DB Page, G Broeckx, CA Jahangir, S Verbandt, RR Gupta, J Thagaard, R Khiroya, Z Kos, K Abduljabbar, G Acosta Haab, B Acs, G Akturk, JS Almeida, I Alvarado-Cabrero, F Azmoudeh-Ardalan, S Badve, NB Baharun, ER Bellolio, V Bheemaraju, KRM Blenman
Modern histologic imaging platforms coupled with machine learning methods have provided new opportunities to map the spatial distr..
B Virassamy, F Caramia, P Savas, S Sant, J Wang, SN Christo, A Byrne, K Clarke, E Brown, ZL Teo, B von Scheidt, D Freestone, LC Gandolfo, K Weber, J Teply-Szymanski, R Li, SJ Luen, C Denkert, S Loibl, O Lucas
2023-03-13
CD8<sup>+</sup> tumor-infiltrating lymphocytes with a tissue-resident memory T (T<inf>RM</inf>) cell phenotype are associated with..